Biotechniques 2000,28(4):732–738 PubMed 61 Saidac DS, Marras SA,

Biotechniques 2000,28(4):732–738.PubMed 61. Saidac DS, Marras SA, Parveen N: Detection and quantification of Lyme spirochetes using sensitive

and specific molecular beacon probes. BMC Microbiol 2009,9(1):43–52.PubMedCentralPubMedCrossRef 62. Parveen N, Leong JM: Identification of a candidate glycosaminoglycan-binding Raf inhibitor adhesin of the Lyme disease spirochete Borrelia burgdorferi . Mol Microbiol 2000,35(5):1220–1234.PubMedCrossRef 63. Morrison TB, Ma Y, Weis JH, Weis JJ: Rapid and sensitive quantification of Borrelia burgdorferi -infected mouse tissues by continuous fluorescent monitoring of PCR. J Clin Microbiol 1999,37(4):987–992.PubMedCentralPubMed 64. Vet JA, Marras SA: Design and optimization of molecular beacon real-time polymerase chain reaction assays. Methods Mol Biol 2005, 288:273–290.PubMed 65. Cornillot E, Hadj-Kaddour K, Dassouli A, Noel B, Ranwez V, BIBW2992 in vitro Vacherie B, Augagneur Y, Bres V, Duclos A, Randazzo S, et al.: Sequencing

of the smallest Apicomplexan genome from the human pathogen Babesia microti . Nucleic Acids Res 2012,40(18):9102–9114.PubMedCentralPubMedCrossRef 66. Huang B, Troese MJ, Ye S, Sims JT, Galloway NL, Borjesson DL, Carlyon JA: Anaplasma phagocytophilum APH_1387 is expressed throughout bacterial intracellular development and localizes to the pathogen-occupied vacuolar membrane. Infect Immun 2010,78(5):1864–1873.PubMedCentralPubMedCrossRef 67. Coumou J, van der Poll T, Speelman P, Hovius JW: Tired of Lyme borreliosis. Lyme borreliosis in the Netherlands. Neth J Med 2011,69(3):101–111.PubMed 68. Stanek G, Fingerle V, Hunfeld see more KP, Jaulhac B, Kaiser R, Krause A, Kristoferitsch W, O’Connell S, Ornstein K, Strle F, et al.: Lyme borreliosis: clinical case definitions for diagnosis and management in Europe. Clin Microbiol Infect 2011,17(1):69–79.PubMedCrossRef 69. Adams DA, Gallagher KM, Jajosky RA, Kriseman J, Sharp P, Anderson WJ, Aranas AE, Mayes M, Wodajo MS, Onweh DH, Abellera JP: Reports of nationally notifiable infectious diseases—United States, 2011. MMWR Morb Mortal Wkly Rep 2013,60(53):1–117.PubMed 70. Schnittger L, Rodriguez AE, Florin-Christensen

M, Morrison DA: Babesia : a world emerging. Infect Genet Evol 2012,12(8):1788–1809.PubMedCrossRef 71. Johnson ST, Cable RG, Tonnetti L, Spencer B, Rios J, Leiby DA: Seroprevalence of Babesia microti in blood donors from Babesia -endemic areas of the northeastern United States: 2000 through 2007. Transfusion 2009,49(12):2574–2582.PubMedCrossRef 72. Tonnetti L, Eder AF, Dy B, Kennedy J, Pisciotto P, Benjamin RJ, Leiby DA: Transfusion-transmitted Babesia microti identified through hemovigilance. Transfusion 2009,49(12):2557–2563.PubMedCrossRef 73. Young C, Chawla A, Berardi V, Padbury J, Skowron G, Krause PJ: Preventing transfusion-transmitted babesiosis: preliminary experience of the first laboratory-based blood donor screening program. Transfusion 2012,52(7):1523–1529.PubMedCrossRef 74.

Comments are closed.